Publications by authors named "Anna Tekielak"

Types diabetes other than type 1 are generally considered rare in children and adolescents. The incidence of type 2 diabetes has increased dramatically over the past decade in some ethnic groups. The increased incidence of this type of diabetes mellitus has corresponded tem-porally to unprecedented increases in body weight and obesity prevalence in adolescents in various ethnic populations.

View Article and Find Full Text PDF

There have been many studies on the association between vitiligo and metabolic syndrome, while only few scientific papers on vitiligo and insulin resistance. In recent years, there have been significant developments in research to trace and understand the aetiology of both conditions. In this article we have analysed pathophysiological mechanisms and the association of insulin resistance (as a component of metabolic syndrome) and vitiligo.

View Article and Find Full Text PDF
Article Synopsis
  • Advances in technology are enhancing glycemic control and lowering complications for type 1 diabetes patients, thus improving their quality of life.
  • Closed-loop insulin delivery systems (HCL) like those from Medtronic, Tandem, and Insulet integrate continuous glucose monitoring (CGM) with insulin pumps to automate insulin delivery, and some are in clinical trials.
  • As these technologies evolve, more advanced systems (AHCL) feature personalized algorithms and improved automation, marking a significant revolution in diabetes management.
View Article and Find Full Text PDF

Phototherapy is a recommended treatment regimen for different scleroderma spectrum disorders, but so far it has been included neither by European nor by worldwide experts committee in recommendations for the treatment of systemic sclerosis (SSc). The aim of the study was to revisit the utility of dermatological phototherapy in patients with SSc. PubMed using medical subject headings was searched to identify studies evaluating response to dermatological phototherapy in SSc patients.

View Article and Find Full Text PDF
Article Synopsis
  • Intensive insulin therapy with Advanced Hybrid Closed Loop (AHCL) technology offers improved management for patients with type 1 diabetes (T1D).
  • A 9-year-old boy treated with the Medtronic AHCL system showed a significant decrease in daily insulin requirements, indicating the system's effectiveness during his remission phase.
  • The AHCL system is a safe and viable therapeutic option for T1D patients, especially during both initial diagnosis and remission phases.
View Article and Find Full Text PDF